No clinical trial is successful without careful attention not only to how endpoints are selected, but how they are reviewed and applied. This article will describe the use of Imaging Core Labs and Endpoint Adjudication Committees (EACs) to increase the quality and accuracy of clinical trial data. Additionally, it will clarify the difference between these critical endpoint review methods and other forms of safety review.
